Post-entry, spike-dependent replication advantage of B.1.1.7 and B.1.617.2 over B.1 SARS-CoV-2 in an ACE2-deficient human lung cell line
Niemeyer, D.; Schroeder, S.; Friedmann, K.; Weege, F.; Trimpert, J.; Richter, A.; Stenzel, S.; Jansen, J.; Emanuel, J.; Kazmierski, J.; Pott, F.; Jeworowski, L. M.; Olmer, R.; Jaboreck, M.-C.; Tenner, B.; Papies, J.; Heinze, J.; Walper, F.; Schmidt, M. L.; Heinemann, N.; Moencke-Buchner, E.; Veith, T.; Baumgardt, M.; Hoffmann, K.; Widera, M.; Thao, T. T. N.; Balazs, A.; Schulze, J.; Mache, C.; Morkel, M.; Ciesek, S.; Hanitsch, L. G.; Mall, M.; Hocke, A. C.; Thiel, V.; Osterrieder, K.; Wolff, T.; Martin, U.; Corman, V. M.; Mueller, M. A.; Goffinet, C.; Drosten, C.
Show abstract
Epidemiological data demonstrate that SARS-CoV-2 variants of concern (VOC) B.1.1.7 and B.1.617.2 are more transmissible and infections are associated with a higher mortality than non-VOC virus infections. Phenotypic properties underlying their enhanced spread in the human population remain unknown. B.1.1.7 virus isolates displayed inferior or equivalent spread in most cell lines and primary cells compared to an ancestral B.1 SARS-CoV-2, and were outcompeted by the latter. Lower infectivity and delayed entry kinetics of B.1.1.7 viruses were accompanied by inefficient proteolytic processing of spike. B.1.1.7 viruses failed to escape from neutralizing antibodies, but slightly dampened induction of innate immunity. The bronchial cell line NCI-H1299 supported 24- and 595-fold increased growth of B.1.1.7 and B.1.617.2 viruses, respectively, in the absence of detectable ACE2 expression and in a spike-determined fashion. Superior spread in NCI-H1299 cells suggests that VOCs employ a distinct set of cellular cofactors that may be unavailable in standard cell lines.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion 98%
- Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 97%
- Characterization of changes in the hemagglutinin that accompanied the emergence of H3N2/1968 pandemic influenza viruses 97%
Similar papers in this journal
- The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission 98%
- Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants 97%
- The genetic driver of Acute Necrotizing Encephalopathy, RANBP2, regulates the inflammatory response to Influenza A virus infection 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.